Bioniche Animal Health discovers, develops, manufactures and markets animal health products worldwide.
Headquartered in Canada, the Company was formed in 1979 to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Bioniche Animal Health is now a division of Bioniche Life Sciences Inc., a public company (TSX: BNC and ASX: BNC).
Bioniche Animal Health markets a broad portfolio of products for companion animals, horses and the livestock industry, with a focus on four key areas:
24 January 2013
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in Canada
BELLEVILLE, ON, January 24, 2013 – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company,... [read more]
13 December 2012
Bioniche Life Sciences Inc. Achieves Registration of Enhance™ I.A./I.V. in Hong Kong
BELLEVILLE, ON, December 13, 2012 – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company,... [read more]
04 December 2012
Bioniche Life Sciences Inc. Launches NexHA™ in Canada
BELLEVILLE, ON, December 4, 2012 – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company,... [read more]
view all recent news![]() |
|||
|
|||
![]() |
![]() |
|||
|
|||
![]() |
![]() |
|||
|
|||
![]() |
![]() |
|||
|
|||
![]() |